Sign In
13 Oct 2008 17:19
ο»Ώ
13 October 2008
REGEN THERAPEUTICS PLCΒ
("ReGen" or the "Company"; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
1.Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
Β
ReGen Therapeutics Plc
Β
2.Reason for the notification:
Β
An acquisition or disposal of voting rights and an event changing the breakdown of voting rights.
Β
3.Full name of person(s) subject to the notification obligation (iii):
Β
Barclays PLC
Β
4.Full name of shareholder(s) (if difference from 3):
Β
Barclays Stockbrokers Ltd
5.Date of the transaction and date on which the threshold is crossed or reached (v):
Β
9 October 2008
Β
6.Date on which issued notified:
Β
13 October 2008
Β
7.Threshold(s) that is/are crossed or reached:
Β
Below notifiable % to 5%
Β
8.Notified detailsΒ
A: Voting rights attached to shares
Class/type of share if possible using the ISIN Code GB00B28XMY25
Situation Previous to the triggering transaction (vi) -
Number of Shares N/A
Number of Voting Rights (viii) N/A
Resulting situation after the triggering transaction (viii) -
Number of Shares 676,151
Number of Voting Rights - Direct (x) N/A
Number of Voting Rights - Indirect (xi) 676,151
% of voting rights - Direct N/A
% of voting rights - Indirect 5.17
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument N/A
Expiration date (xiii) N/A
Exercise/Conversion Period/Date (xiv) Β N/A
Number of voting rights that may be acquired if theΒ
instrument is exercised/converted N/A
% of voting rights N/A
Total (A+B)
Number of voting rights 676,151
% of voting rights 5.17
9.Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):Β Barclays Stockbrokers Ltd
Proxy Voting:
Β
10. Name of the proxy holder: N/A
Β
11. Number of voting rights proxy holder will cease to hold: N/A
Β
12. Date on which proxy holder will cease to hold voting rights: Β Β N/A
Β
13. Additional information: N/A
Β
14. Contact name: Geoff Smith
Β
15.Contact telephone number: 0207 116 2913
For further information:
For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396Β
Follow the stocks
